Research Topics
| W S WeintraubSummaryAffiliation: Christiana Care Health System Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Comparative effectiveness of revascularization strategiesWilliam S Weintraub
Christiana Care Health System, Newark, DE 19718, USA
N Engl J Med 366:1467-76. 2012..The American College of Cardiology Foundation (ACCF) and the Society of Thoracic Surgeons (STS) collaborated to compare the rates of long-term survival after PCI and CABG...
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data RegistryWilliam S Weintraub
Christiana Care Health System, 4755 Ogletown Stanton Road, Newark, DE 19718, USA
Circulation 125:1501-10. 2012..The purpose of this study was to develop a long-term model to predict mortality after percutaneous coronary intervention in both patients with ST-segment elevation myocardial infarction and those with more stable coronary disease...
Cutting through the statistical fog: understanding and evaluating non-inferiority trialsW S Weintraub
John H Ammon Chair, Thomas Jefferson University, Philadelphia, PA, USA
Int J Clin Pract 64:1359-66. 2010..Objectives and primary end-points must be clearly stated and rigorous standards met for sample size, establishing the margin, patient characteristics and adherence to protocol...
Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an exampleWilliam S Weintraub
Christiana Care Health System, Center for Heart and Vascular Health, Newark, Delaware 19718, USA
J Cardiovasc Pharmacol Ther 13:107-19. 2008..Greater clinician understanding of pharmacoeconomic principles (and pitfalls) will enhance input of the physicians into the decision-making process to maximize the benefit of limited health care resources...
Effect of PCI on quality of life in patients with stable coronary diseaseWilliam S Weintraub
Christiana Care Health System, Newark, DE 19718, USA
N Engl J Med 359:677-87. 2008..It has not been clearly established whether percutaneous coronary intervention (PCI) can provide an incremental benefit in quality of life over that provided by optimal medical therapy among patients with chronic coronary artery disease...
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub
Atlanta VA Medical Center, Decatur, GA, USA
Am Heart J 151:1180-5. 2006..A multilevel regression model will assess cost-effectiveness from a net benefit perspective. These approaches should provide the most detailed assessment available of the cost-effectiveness of PCI for coronary artery disease...
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patientsWilliam S Weintraub
Christiana Care Health System, Newark, DE 19718, USA
Circ Cardiovasc Qual Outcomes 1:12-20. 2008..After 4.6 years, there was no difference in the primary end point of death or myocardial infarction, although PCI improved quality of life. The present study evaluated the relative cost and cost-effectiveness of PCI in the COURAGE trial...
Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes?William S Weintraub
Christiana Care Health System, Newark, DE 19718, USA
Nat Clin Pract Cardiovasc Med 5:754-5. 2008..Although available data are not based on the latest technology, another trial in this area would be difficult to conduct and of questionable ethics...
The pathophysiology and burden of restenosisWilliam S Weintraub
Department of Cardiology and Christiana Center for Outcomes Research, Christiana Care Health Services, Newark, Delaware 19718, USA
Am J Cardiol 100:3K-9K. 2007..Recent studies suggest that the pharmacologic management of restenosis is now feasible. Together, the judicious use of stents and oral pharmacotherapy promise to reduce the risk for restenosis, even among high-risk patients...
Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass graftingVinod H Thourani
Joseph B. Whitehead Department of Surgery, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Atlanta, GA, USA
Circulation 108:298-304. 2003..However, in the present series, MV repair does not provide significant long-term survival benefit over MV replacement in patients older than 60 years of age or those requiring concomitant CABG...
Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995C D Warner
Emory Healthcare, Atlanta, GA, USA
Circulation 96:1575-9. 1997....
Improving cost and outcome of coronary surgeryW S Weintraub
Division of Cardiology, School of Medicine, Health Policy and Management, Emory University, Atlanta, GA, USA
Circulation 98:II23-8. 1998..There has been increasing interest in improving the outcome of coronary surgery while also seeking to minimize cost. It was the purpose of the present study to determine changes in the outcome and cost of CABG between 1988 and 1996...
Invited commentaryWilliam S Weintraub
Christiana Care Health Services, 4755 Ogletown-Stanton Rd, Newark, DE19718
Ann Thorac Surg 82:810-1. 2006
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trialPaul Kolm
Christiana Care Health System, Newark, Delaware, USA
Can J Cardiol 23:1037-42. 2007....
Coronary stent restenosis in patients treated with cilostazolJohn S Douglas
Emory University School of Medicine, Atlanta, GA, USA
Circulation 112:2826-32. 2005..We undertook a randomized, double-blind, placebo-controlled trial to determine whether cilostazol, a drug that suppresses intimal proliferation, would reduce renarrowing in patients after stent implantation in native coronary arteries...
The risk of cardiovascular events in primary care patients following an episode of severe hypertensionEdward Ewen
Christiana Care Health System, Center for Outcomes Research, Newark, DE 19713, USA
J Clin Hypertens (Greenwich) 11:175-82. 2009..1 in the mild group, 15.1 in the moderate group, and 25.0 in the severe group. An episode of severe BP elevation is common in primary care practice and is associated with substantial excess cardiovascular morbidity...
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary interventionEdward F Ewen
Christiana Care Health System, Center for Outcomes Research, Newark, Delaware 19713, USA
J Interv Cardiol 22:266-73. 2009..This retrospective analysis examines and contrasts the in-hospital cost of bleeding associated with this procedure using six bleeding definitions employed in recent clinical trials...
Comparison of recovery after mitral valve repair and replacementLiping Zhao
Christiana Care Health System, Newark, Del 19713, USA
J Thorac Cardiovasc Surg 133:1257-63. 2007..We sought to examine the comparative improvement in health status after primary mitral valve repair versus replacement in patients with mitral valve regurgitation in a longitudinal setting...
Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trialZefeng Zhang
Christiana Care Health System, Newark, DE 19713, USA
Am Heart J 152:770-6. 2006..4% vs 16%, P = .90) for the 2 treatment groups, but restenosis rate was lower (22.0% vs 34.5%, P = .002) in cilostazol-treated patients. We sought to evaluate resource use, cost, and cost-effectiveness of cilostazol in CREST...
The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trialZefeng Zhang
Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, DE 19713, USA
Am Heart J 152:1153-60. 2006..Relative outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) may differ between younger and older patients. There are no data comparing the age-related CABG versus PCI outcomes in the stent era...
Emergency department tachypnea predicts transfer to a higher level of care in the first 24 hours after ED admissionHeather Farley
Christiana Care Health System, Newark, DE, USA
Acad Emerg Med 17:718-22. 2010..The authors hypothesized that vital sign abnormalities detected in the emergency department (ED) can be used to forecast clinical deterioration occurring within 24 hours of hospital admission...
Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertensionDeborah B Ehrenthal
Department of Obstetrics and Gynecology, Christiana Care Health Services, Newark, DE 19718, USA
J Womens Health (Larchmt) 20:67-72. 2011..With the rising prevalence of obesity, the role of prepregnancy body mass index (BMI) as an independent risk factor for PIH and a target for preconception care is important to explore...
Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) studyLeo Marcoff
Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, Delaware 19718, USA
J Am Coll Cardiol 54:1271-9. 2009..We used a U.S. model of health care costs to examine the cost effectiveness of enoxaparin compared with unfractionated heparin (UFH) as adjunctive therapy for fibrinolysis in patients with ST-segment elevation myocardial infarction (STEMI)...
Predictors and outcomes associated with early extubation in older adults undergoing coronary artery bypass surgeryJ L Bezanson
Scientific Research Solutions, Inc, Roswell, GA, USA
Am J Crit Care 10:383-90. 2001..The variables comorbid conditions and severity of illness provided better discrimination between extubation groups than a physiological model provided. Both predictive models allowed limited discrimination between groups...
Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support modelW S Weintraub
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Circulation 102:392-8. 2000..However, uncertainty exists regarding the cost-effective selection of patients to receive antiplatelet therapy...
Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery diseaseS J Dempsey
Center for Heart Failure Therapy, Emory University Hospital, 1364 Clifton Road, N E, Suite F508, Atlanta, GA, 30322, USA
J Invasive Cardiol 12:311-5. 2000..There are limited data on the use of percutaneous revascularization techniques for transplant coronary artery disease (CAD)...
Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrestVinay R Hosmane
Department of Medicine Cardiology, Christiana Care Health System, Newark, Delware 19718, USA
J Am Coll Cardiol 53:409-15. 2009..We examined outcomes of patients resuscitated from cardiac arrest owing to ST-segment elevation myocardial infarction (STEMI) and predictors of survival and neurologic recovery...
Coronary artery disease: revascularization strategies for patients with CAD and diabetesG Robert Myers
Section of Cardiology, Room 2E99, Christiana Hospital, 4755 Ogletown Stanton Road, Newark, DE 19718, USA
Nat Rev Cardiol 7:364-6. 2010..The results of a new analysis of data from the SYNTAX trial challenge this conventional wisdom and highlight additional coronary revascularization options to physicians and patients...
Twenty-year survival after coronary artery surgery: an institutional perspective from Emory UniversityWilliam S Weintraub
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Circulation 107:1271-7. 2003..However, uncertainty exists regarding the relationship between long-term survival after CABG and readily available clinical correlates of mortality...
Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist eraZiyad Ghazzal
Andreas Gruentzig Cardiovascular Center of Emory University School of Medicine, Division of Cardiology, Atlanta, GA, USA
Am Heart J 145:1006-12. 2003..We evaluated the significance of creatine phosphokinase level (CPK) elevations in a large cohort of patients who had undergone an elective PCI before the IIb/IIIa receptor antagonist era...
Cost and cost-effectiveness studies in heart failure researchWilliam S Weintraub
Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA
Am Heart J 143:565-76. 2002..In the United States alone, the prevalence is 4.6 million, with an incidence rate of 550,000 new cases a year and approximately 957,000 hospitalizations a year...
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trialJohn D Puskas
Division of Cardiothoracic Surgery, Emory University School of Medicine and Emory Center for Outcomes Research, Atlanta, GA, USA
JAMA 291:1841-9. 2004..A preliminary report showed OPCAB achieved improved inhospital outcomes, similar completeness of revascularization, and shorter lengths of stay compared with conventional coronary artery bypass grafting (CABG)...
Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trialZ Zhang
Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA
Am Heart J 142:982-8. 2001..02). CONCLUSIONS: The Duett sealing device was associated with significantly higher functional status at 7 days after the procedure in addition to shortened time to hemostasis and ambulation, with no associated increase in cost...
Is a paradigm shift in US healthcare reimbursement inevitable?William S Weintraub
Emory University, Atlanta, GA, USA
Circulation 109:1448-55. 2004
Comparison of outcomes of percutaneous coronary intervention of ostial versus nonostial narrowing of the major epicardial coronary arteriesKreton Mavromatis
Division of Cardiology, Atlanta VA Medical Center, Decatur, Georgia, USA
Am J Cardiol 94:583-7. 2004..However, at 1 year, patients who underwent ostial PCI had an increased rate of repeat revascularization compared with patients who underwent nonostial, proximal PCI...
Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II TrialDaniel J Elliott
University of Pennsylvania Division of General Internal Medicine, Philadelphia, PA, USA
Am Heart J 156:374.e1-6. 2008..The aim of the study was to compare the health status outcomes of patients who undergo TEE-guided cardioversion with enoxaparin or unfractionated heparin as anticoagulation bridging therapy...
Assessing data adequacy for clinical research: reliability and validity of a surgical databaseJudy L Bezanson
Scientific Research Solutions, Inc, Roswell, GA, USA
J Nurs Meas 10:155-64. 2002..Using the same external standard to assess both reliability and validity was a significant limitation of this study, which resulted in the same measure of data adequacy by utilizing differing statistical methods...
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])Sunil V Rao
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 97:1478-81. 2006..Randomized clinical trials are needed to confirm the efficacy of DESs in these clinical and angiographic settings. These data also highlight the importance of multicenter registries in tracking new technologies...
The vascular effects of cilostazolWilliam S Weintraub
Emory Center for Outcomes Research, Emory University, Atlanta, Georgia 30322, USA
Can J Cardiol 22:56B-60B. 2006....
Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424William E Boden
VA Connecticut Healthcare System, West Haven, CT, USA
Am Heart J 151:1173-9. 2006....
Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent eraSalman Ashfaq
University of Kansas School of Medicine-Wichita, Wichita, Kansas, USA
J Invasive Cardiol 18:100-5. 2006..The effect on long-term outcomes using these newer devices in diabetic subjects undergoing SVG PCI must be established for a true assessment of their impact...
Patterns and outcomes of drug-eluting coronary stent use in clinical practiceSunil V Rao
The Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 152:321-6. 2006..To determine patterns and outcomes of drug-eluting stents (DES) use in clinical practice...
The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialWilliam E Boden
VA Connecticut Healthcare System, West Haven, Connecticut, USA
Am J Cardiol 99:208-12. 2007....
Optimal medical therapy with or without PCI for stable coronary diseaseWilliam E Boden
Western New York Veterans Affairs Healthcare Network and Buffalo General Hospital SUNY, Buffalo, NY 14203, USA
N Engl J Med 356:1503-16. 2007....
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data RegistryLeslee J Shaw
Emory Program in Cardiovascular Outcomes Research and Epidemiology, 1256 Briarcliff Rd NE, Suite 1 N, Emory University School of Medicine, Atlanta, GA 30306, USA
Circulation 117:1787-801. 2008..Although populations referred for coronary angiography are increasingly diverse, there is limited information on coronary artery disease (CAD) prevalence and in-hospital mortality other than for predominately white male patients...
The Seattle angina questionnaire: reliability and validity in women with chronic stable anginaLaura P Kimble
School of Nursing, Emory University, Atlanta, Georgia 30322, USA
Heart Dis 4:206-11. 2002..Future research is needed to determine whether examining different combinations of SAQ items might provide a more sensitive assessment of cardiac disease-specific quality of life in women...
Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevationElizabeth M Mahoney
New England Research Institutes, Watertown, MA 02472, USA
Am Heart J 151:219-27. 2006..We evaluated the long-term cost-effectiveness of clopidogrel use for up to 1 year using patient-level outcomes and resource use from PCI-CURE, and estimates of life expectancy gains based on external sources...
Rationale and design of the randomized, multicenter, cilostazol for RESTenosis (CREST) trialJohn S Douglas
Division of Cardiology, Emory Center for Outcomes Research, Emory University School of Medicine, Atlanta, Georgia, USA
Clin Cardiol 26:451-4. 2003..The CREST trial is a large, rigorously conducted trial that may corroborate the favorable effects of cilostazol on coronary stent restenosis suggested by earlier studies...
Gender differences in pain characteristics of chronic stable angina and perceived physical limitation in patients with coronary artery diseaseLaura P Kimble
Emory University School of Nursing, 1520 Clifton Rd, NE, Atlanta, GA 30322, USA
Pain 101:45-53. 2003....
Economics of sirolimus-eluting stents: drug-eluting stents have really arrivedWilliam S Weintraub
Circulation 110:472-4. 2004
Methods for the economic and quality of life supplement to the cilostazol for RESTenosis (CREST) trialWilliam S Weintraub
Division of Cardiology, Emory University, Atlanta, Georgia, USA
J Invasive Cardiol 16:257-9. 2004....
Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National CardiRonald J Krone
Department of Medicine, Washington University, St Louis, Missouri, USA
Am J Cardiol 92:389-94. 2003....
Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial)Zefeng Zhang
Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30306, USA
Am J Cardiol 93:404-9. 2004..049 for the interaction among treatment, gender, and follow-up for the quality of life domain). Although CABG may be superior to PCI in men, in women, at 1 year after intervention, both procedures appear equally effective...
Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trialZefeng Zhang
Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
Circulation 108:1694-700. 2003..During the first postprocedure year, patients' angina burden and physical limitations were alleviated to a greater extent with CABG...
Restenosis: are the implications changing?Jason H Cole
Am Heart J 147:197-9. 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and thMarc S Sabatine
TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
Circulation 109:874-80. 2004..We sought to examine the effect of these advances on clinical outcomes and the benefits of an early invasive strategy in UA/NSTEMI...
Are stenting and glycoprotein IIb/IIIa blockade of good value in primary percutaneous coronary intervention?Jason H Cole
Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
Circulation 108:2831-3. 2003
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarctionElizabeth M Mahoney
Emory Center for Outcomes Research, Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1256 Briarcliff Rd, Suite 1N, Atlanta, GA 30306, USA
JAMA 288:1851-8. 2002....
Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillationElizabeth M Mahoney
Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia, USA
J Am Coll Cardiol 40:737-45. 2002..This study evaluated the cost-effectiveness of administering prophylactic intravenous (IV) amiodarone therapy to patients undergoing cardiac surgery according to their predicted risk of postoperative atrial fibrillation...
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) triaSean C Beinart
Emory University, Atlanta, Georgia, USA
J Am Coll Cardiol 46:761-9. 2005..CONCLUSIONS: Platelet inhibition with clopidogrel loading before PCI followed by therapy for one year is highly cost effective...
The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trialZefeng Zhang
Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30306, USA
Am Heart J 150:175-81. 2005..Data are limited regarding the impact of acute coronary syndromes (ACSs) on the relative benefits of coronary artery bypass grafting (CABG) versus stent-assisted percutaneous coronary intervention (PCI)...
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatmentMarc S Sabatine
TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, Mass 02115
Circulation 111:1217-24. 2005..Whether the disparate outcomes exist independently of potential biases in treatment patterns remains unclear...
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevationWilliam S Weintraub
Emory University, Atlanta, Georgia, USA
J Am Coll Cardiol 45:838-45. 2005..We sought to evaluate the long-term cost-effectiveness of clopidogrel for up to one year after an acute coronary syndrome (ACS) without ST-segment elevation...
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failureWilliam S Weintraub
Emory University, 1256 Briarcliff Rd, Suite 1N, Atlanta, GA 30306, USA
Circulation 111:1106-13. 2005..The present study was performed to evaluate the cost-effectiveness of eplerenone compared with placebo in these patients...
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE studyAndre Lamy
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
Eur J Cardiovasc Prev Rehabil 11:460-5. 2004..The CURE study demonstrated that clopidogrel prevents a range of ischaemic cardiovascular events in patients with Acute Coronary Syndromes (unstable angina or non-ST-segment elevation MI)...
Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) TrialPeter Wahrborg
Department of Cardiology, Sahlgrenska University Hospital, S 413 45 Gothenburg Sweden
Circulation 110:3411-7. 2004..However, little is known about the impact of percutaneous coronary intervention (PCI) on neuropsychological outcome...
Summary of special topics presentations of the American College of Cardiology 52nd annual meeting, 2003William S Weintraub
Department of Medicine, Emory University, Atlanta, Georgia 30306, USA
J Am Coll Cardiol 42:383-5. 2003
Association between gender and in-hospital mortality after percutaneous coronary intervention according to ageJerome L Abramson
Department of Medicine, Division of Cardiology, Emory University School of Medicine, 1256 Briarcliff Road, Suite 1 North, Atlanta, GA 30306, USA
Am J Cardiol 91:968-71, A4. 2003
Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000Richard E Shaw
San Francisco Heart Institute at Seton Medical Center, Daly City, California 94015, USA
J Am Coll Cardiol 39:1104-12. 2002..We sought to develop and evaluate a risk adjustment model for in-hospital mortality following percutaneous coronary intervention (PCI) procedures using data from a large, multi-center registry...
Long-term follow-up of coronary artery disease presenting in young adultsJason H Cole
Emory Center for Outcomes Research and Section of Preventive Cardiology, Division of Cardiology, Emory University School of Medicine, Emory University, 1525 Clifton Road, Atlanta, GA 30322, USA
J Am Coll Cardiol 41:521-8. 2003..CONCLUSIONS: Coronary disease in young adults can carry a poor long-term prognosis. A prior MI, diabetes, active tobacco abuse, and lower EF predict a significantly higher mortality...
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study)John A Spertus
Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA
Am Heart J 143:636-42. 2002....
A comparison of self-selectivity corrections in economic evaluations and outcomes researchJinook Jeong
Department of Economics, Yonsei University, Seoul, Korea, and Ralph H Johnson VA Medical Center, Charleston, SC, USA
Value Health 8:656-66. 2005..This article reviews and empirically tests the two alternative selectivity correction methods to give a reality-based evaluation...
Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) studyClaudine T Jurkovitz
Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia 30306, USA
J Am Soc Nephrol 14:2919-25. 2003..86 to 1.67). In conclusion, this study indicates that high Scr is associated with almost a threefold risk of CHD among middle-aged people with anemia, whereas no increased risk is found in people with high Scr in the absence of anemia...
Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry reportSorin J Brener
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
Am Heart J 155:140-6. 2008..Although an early invasive strategy improves outcome in these patients, there are limited data on culprit-only, single-vessel (SV) percutaneous coronary intervention (PCI) or MV PCI in the NSTE ACS setting...
Cost-effectiveness of eplerenone in patients with left ventricular dysfunction after myocardial infarction--an analysis of the EPHESUS study from a Swiss perspectiveThomas D Szucs
Institute of Social and Preventive Medicine, University of Zurich, Gloriastrasse 18a, CH 8006 Zurich, Switzerland
Cardiovasc Drugs Ther 20:193-204. 2006..The EPHESUS pharmacoeconomic analysis was performed to evaluate the cost-effectiveness of eplerenone in the Swiss setting...
The synergistic effect of heart disease and diabetes on self-management, symptoms, and health statusChristi Deaton
The University of Manchester, Manchester, United Kingdom
Heart Lung 35:315-23. 2006..Clinicians' understanding of this synergy and integration of condition-specific care with general treatment and self-management practices are needed...
Variability in the clinical status of patients with advanced heart failurePaul J Hauptman
Department of Medicine, Saint Louis University School of Medicine, Missouri, USA
J Card Fail 10:397-402. 2004....
Time course of depression and outcome of myocardial infarctionSusmita Parashar
Divisions of General Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA
Arch Intern Med 166:2035-43. 2006..Our objective was to evaluate the prognostic importance of transient, new, or persistent depression on outcomes at 6 months after MI...
Multicenter experience in revascularization of very elderly patientsEric D Peterson
The Outcomes Research and Assessment Group, The Duke Clinical Research Institute, Durham, NC 27715, USA
Am Heart J 148:486-92. 2004..We pooled the largest PCI and CABG clinical registries in the United States to better understand revascularization procedure use, risks and outcomes in patients aged > or =75 years...
Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendationsH Vernon Anderson
University of Texas Health Science Center, Houston, Texas, USA
Am J Cardiol 99:189-96. 2007..With further refinement, these methods should be able to be used as powerful analytic tools for quality assurance and appropriateness purposes...
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach
Cardiovascular Division, Washington University Medical Center, St Louis, Missouri 63110, USA
Ann Intern Med 141:186-95. 2004..Although increasing age is an important risk factor for adverse outcome among patients with acute coronary syndromes, elderly patients are more often managed conservatively...
Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeksAllan L Klein
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
J Am Coll Cardiol 43:1217-24. 2004....
Predictors of weight change in overweight patients with myocardial infarctionYazid Y Fadl
Washington University in St Louis, St Louis, MO, USA
Am Heart J 154:711-7. 2007..Weight loss is recommended among overweight survivors of myocardial infarction (MI). This study describes patterns of weight change among overweight patients with MI and identifies factors associated with weight change...
A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)H Vernon Anderson
Texas Heart Institute and the University of Texas, Houston 77030, USA
J Am Coll Cardiol 39:1096-103. 2002..These data reconfirm overall acceptable results that are consistent with other reported data, but also confirm large variations between individual institutions...
Research Grants
- EXERCISE AND CARDIOVASCULAR DISEASEWilliam Weintraub; Fiscal Year: 2003..Not only existing markers of oxidative stress, but also novel surrogate markers, such as, plasma soluble VCAM-l, myeloperoxidase, and autoantbodies to oxidatively modified proteins will be measured. ..
